TACSTD2 and urinary bladder carcinoma: Finally, a proteomic analysis identified 2964 proteins in the urine exosomes of 28 bladder cancer patients, revealing that exosomal trophoblast cell surface antigen 2 (TACSTD2) was significantly higher in the patients’ urine than in individuals with hernias.